Document:

EX-10.12

 Exhibit 10.12 

WORK ORDER #2 

This Work Order dated June 24, 2021 by and between Castle Creek Biosciences, LLC (“Castle Creek”) and John Maslowski,
(“Consultant”) and is incorporated into the Master Consulting Agreement dated June 24, 2021 (“Agreement”) by and between Castle Creek and Consultant. This Work Order describes Services to be performed and provided by
Consultant pursuant to the Agreement. In the event of any conflict between the Agreement and any provision of this Work Order, the Agreement will control unless the Parties’ intent to alter the terms of the Agreement is expressly set forth in
such provision, and such alteration shall only apply to this Work Order and shall not be construed as an amendment to the terms of the Agreement. All capitalized terms used and not expressly defined in this Work Order will have the meanings given to
them in the Agreement. 
  

	1.	 Scope of Work: 

 

	 	•	 	 Establish and chair the Castle Creek Scientific Advisory Board (SAB). 

 

	2.	 Deliverable(s): The tangible items arising out of the Scope of Work.

  

	3.	 Fees: Commencing January 1, 2022, $1,125 per calendar quarter.

  

	4.	 Term and Termination. The term of this Work Order #2 shall continue indefinitely, until
terminated by a Party as set forth herein. Either Party may terminate this Work Order #2, or any particular Services listed herein at any time by providing the other Party fifteen (15) days prior written notice of its intent to terminate. This
Section 4 shall supersede anything to the contrary as set forth in the Agreement. 

 IN WITNESS WHEREOF, the duly authorized
representatives of the Parties hereto have caused this Work Order to be duly executed as of the last date set forth below. 
  

									
	Castle Creek Biosciences, LLC	  		  	John Maslowski
					
	By:	  	 /s/ Matt Gantz
	  	    	  	By:	  	 /s/ John Maslowski

	Name:	  	  
	  		  	Name:	  	  

	Title:	  	  
	  		  	Title:	  	  

	Date:	  	  
	  		  	Date:	  	  

  

			
	CONFIDENTIAL	  	Page 1 of 1EX-10.16

 Exhibit 10.16 

 

			
	

	  	 90 Washington Valley Road

Bedminster, NJ 07921

 Dear Mr. Wujek, 
 On behalf
of Castle Creek Pharmaceuticals, LLC (“Castle Creek” or the “Company”), I am pleased to extend an offer of full-time employment to you with the Company as Vice President, Market Access—reporting directly to the EVP/Chief
Commercial Officer. 
 Your start date will be on or about October 3, 2016, or as otherwise mutually agreed upon. We are excited about you joining the
team at Castle Creek and hope you will accept our offer to join us in executing our growth plans for the Company. 
 The terms of your employment offer are
outlined below: 
  

	 	•	 	 You will be employed by the Company on a full-time basis, at a bi-monthly
base pay of $9,792 which, when annualized, is equivalent to $235,000 per year. 

  

	 	•	 	 Participation (pro-rated for 2016) in the Company’s Performance
Bonus Plan at a maximum of 30% of your base salary based on Company and individual achievement. Your bonus will be based on your performance meeting established individual goals and objectives to support the growth strategy of the Company, as well
as the Company’s overall performance, and shall be determined by the Company’s Board of Managers. Goals will be agreed upon and established annually on both a corporate and individual basis. 

 

	 	•	 	 Following your start date and subject to board approval, you will be awarded 1,750 Value Appreciation Rights (or
VARs) under and subject to the Company’s Amended and Restated 2015 Management Incentive Plan, pursuant to which you will be eligible to receive an amount with respect to each vested VAR (in cash, Incentive Units or some combination thereof)
equal to the excess of the Fair Market Value of an Incentive Unit at the time of exercise over the exercise price of the VAR (determined as of the date of grant). The VARs will be subject to vesting at the rate of 20% of the VARs awarded on each of
the first (5) anniversaries of the date of grant, subject to your continued employment with the Company on each vesting date, provided that unvested VARs will be accelerated on a “change in control” of the Company during your service
with the Company. Such VARs will be subject to approval by the Committee, and will be memorialized in a Value Appreciation Right Award Agreement with these terms and such other terms as the Committee determines, and you will have no legal right to
the VARs until they are approved by the Committee and evidenced in such award agreement. 

	 	•	 	 As a full-time Company employee, you will be eligible to participate in the Employee Benefit Plans which includes
medical, dental and vision benefits, 75% paid by the Company, and the 401(k) and long term disability plans that the company puts in place. 

  

	 	•	 	 As a full-time Company employee you will accrue paid vacation and sick leave. Vacation will accrue at a rate of
1.25 days per month, or 15 days per year. 

  

	 	•	 	 You will devote all of your work time and attention to the Company, including, but not limited to, its business,
operations and success. 

 This offer of employment, if not previously accepted by you, will expire in ten days. This offer of employment
does not represent an employment contract. Just as you retain the right to resign, with or without notice or cause, Castle Creek has the same right with respect to termination of your employment. You will be an employee at will, and your employment
is for no definite term, regardless of any other oral or written statement by any Castle Creek, with the exception of an express written employment contract approved by the Company’s Board of Managers. 

Best Regards, 
 /s/ John Koconis 

John Koconis 
 Executive Vice President and Chief Commercial
Officer 
 Castle Creek Pharmaceuticals LLC 
 Offer Acceptance:

  

			
	By:	 	 /s/ Gregory F. Wujek

	Name:	 	Gregory F. Wujek
	Date:	 	September 27, 2016EX-10.17

 Exhibit 10.17 

 

			
	 

	  	 6 Century Drive, 2nd Floor

Parsippany, NJ 07054

 April 9, 2019 

Dr. Mary Spellman 
 28 Miguel Street 

San Francisco, CA 94131 
 Dear Mary, 

On behalf of Castle Creek Pharmaceuticals, LLC (“Castle Creek” or the “Company”), I am pleased to extend an offer of full-time employment
to you with the Company as Senior VP of Research & Development and Medical Affairs and Chief Medical Officer. You will report to the EVP, Research and Development, Paragon Biosciences, LLC, and to the CEO, Castle Creek. 

Your start date will be mutually determined but we anticipate it to be on or around June 3, 2019. You will be paid on a
bi-monthly basis as noted in the terms of employment below. We are excited about the possibility of you joining our team at Castle Creek and hope you will accept our offer to join us in executing our growth
plans for the Company. 
 The terms of your employment offer are outlined below: 
  

	 	•	 	 Bi-monthly base pay of $17,916.67 which, when annualized, is equivalent
to a base salary of $430,000 per year. 

  

	 	•	 	 Participation (pro-rated for the calendar year in which your actual start
date occurs) in the Castle Creek Pharmaceuticals, LLC Performance Bonus Plan at up to 50% of your base salary based on Company and individual achievement. Your annual bonus will be based on your performance meeting established individual goals and
objectives to support the growth strategy of the Company, as well as the Company’s overall performance.  

  

	 	•	 	 Equity in the Company’s parent company -Castle Creek Pharmaceutical Holdings, Inc. (the “Parent
Company”)—in the amount of 5,000 stock options under its amended and restated management incentive plan (the “Plan”) at an exercise price per share equal to the then fair market value thereof as determined by its Board of
Directors. Such stock options shall vest 20% per year on each anniversary of your employment with the Company in accordance with the Plan, provided that you remain employed by the Company on each such anniversary, subject to accelerated vesting on a
Change in Control as defined in the Plan. 

  

	 	•	 	 In consideration of the money left behind at your current employer for 2019
pro-rated annual bonus, you will receive a sign-on bonus of $65,000 (subject to applicable tax and other withholding). If you leave the company for any reason within 6
months after receiving payment, you must pay back the full pre-tax amount of that payment to Castle Creek Pharma. 

	 	•	 	 Upon completion of 12 months of employment with the Company, you will be entitled to one year’s base salary
as severance if your employment is subsequently terminated by the Company without cause. 

  

	 	•	 	 Supplemental income to cover reasonable relocation expenses in connection with your move to the Chicagoland area
in the amount of up to $25,000, as determined by the Company’s Chief Executive Officer. 

  

	 	•	 	 As a full-time Company employee, you will accrue paid vacation and sick leave. Vacation will accrue at a rate of
1.25 days per month, or 15 days per year. 

  

	 	•	 	 As a full-time employee of the Company, except as expressly provided for above, you are eligible to participate
in the provided Castle Creek Pharmaceuticals, LLC Employee Benefit Plans. 

  

	 	•	 	 This offer is contingent upon successful completion of our pre-employment
processes, including background verification. By signing and returning a copy of this offer letter to me, you expressly consent to such background verification and other pre-employment processes.

  

	 	•	 	 You will devote all of your time and attention to the Company (including, but not limited to, its business,
operations and success) and shall not compete with the Company in any way during your employment. 

 This offer of employment, if not
previously accepted by you, will expire ten days after the date first set forth above. This offer of employment does not represent an employment contract. Just as you retain the right to resign, with or without notice or cause, Castle Creek has the
same right with respect to termination of your employment. You will be an employee at will, and your employment is for no definite term, regardless of any other oral or written statement by any Castle Creek officer or representative, with the
exception of an express written employment contract signed by the Chairman of the Board, President or the Executive Vice President of Legal Affairs and General Counsel of the Company. 

If you understand and accept these terms, please sign and return one copy of this offer letter to me. We would love to have you join Castle Creek
Pharmaceutical and be a part of building a great company. Should you have any questions regarding this offer, please feel free to contact me at 847-715-0611. 

Sincerely, 
 /s/ Anna Fenkanyn 

Anna Fenkanyn 
 Human Resources 

Agreed to and Accepted by: 
  

							
	 /s/ Mary Spellman
	 	                                      
      	  		  	 09 April 2019

	Dr. Mary Spellman	 		  		  	Date

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}]]